What’s Next For VBI Vaccines (VBIV) Stock? Analyst Weighs In

The race to be first to market with a Covid-19 vaccine is already in advanced stages with several names deep into their candidates’ Phase 3 trials.While several “big pharma” representatives are among the leading pack, the coronavirus has also provided several small cap biotechs a platform on which to gain traction.A latecomer to the race is VBI Vaccines (VBIV). The company certainly won’t make it across the finish line first, but as the pandemic evolves, could have a role to play further down the line.VBI recently secured $42 million in funding from the Canadian government to advance development of its …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.